These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2667667)

  • 1. Evasion of Trypanosoma cruzi from complement lysis.
    Kipnis TL; da Silva WD
    Braz J Med Biol Res; 1989; 22(1):1-16. PubMed ID: 2667667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase.
    Kipnis TL; Tambourgi DV; Sucupira M; Dias-da-Silva W
    Braz J Med Biol Res; 1986; 19(2):271-8. PubMed ID: 3548858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
    Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
    Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A; Hieny S; Joiner K
    J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.
    Iida K; Whitlow MB; Nussenzweig V
    J Exp Med; 1989 Mar; 169(3):881-91. PubMed ID: 2494292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
    Rimoldi MT; Sher A; Heiny S; Lituchy A; Hammer CH; Joiner K
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):193-7. PubMed ID: 3277170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
    Norris KA; Bradt B; Cooper NR; So M
    J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.
    Joiner KA; daSilva WD; Rimoldi MT; Hammer CH; Sher A; Kipnis TL
    J Biol Chem; 1988 Aug; 263(23):11327-35. PubMed ID: 3042767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ramírez-Toloza G; Ferreira A
    Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
    Rimoldi MT; Tartanian A; Joiner KA
    Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.
    Tambourgi DV; Kipnis TL; da Silva WD; Joiner KA; Sher A; Heath S; Hall BF; Ogden GB
    Infect Immun; 1993 Sep; 61(9):3656-63. PubMed ID: 7689538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.